“…Heterocyclic substitution may cause changes in the degree of ionization of compounds in physiological pH, resulting in variations of basicity and lipophilicity . Biological activities and pharmaceutical uses attributed to heterocycles as part of active molecules include antitubercular, analgesic, antipyretic, anti-inflammatory, antiplatelet, anti-HIV, antagonist, CNS depressant, antifungal, antibacterial, antioxidant, and anticancer activities. – Amid the many prominent anticancer scaffolds that have replaced one or both aromatic rings in organic chalcones include diazepines, indoles, triazoles, thiazoles, thiophenes, and imidazolones, among many others. – These compounds exhibited IC 50 values ranging from 0.16 to 11 μM toward breast, lung, colon, cervix, leukemia, and cancer cell lines ,– Including ferrocene in the chalcone moiety has been explored toward the search for novel anticancer agents. Among those studied are furan, pyrazole, and piperazine-bearing ferrocene–chalcone hybrids with IC 50 values as low as 1 μM toward MDA-MB-231. – This study aims to further broaden the library of ferrocene–chalcone hybrids by synthesizing 15 novel compounds bearing azoles, pyrimidines, pyrrole, and indole moieties.…”